MedTrace Logo

Lignocaine Nebulization for Attenuation of Intubation Stress Response

NCT04441073 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-01-19

No results posted yet for this study

Summary

To study the effect of lignocaine nebulization on attenuation of the pressor response during induction and emergence of anesthesia in patients with severe pre-eclampsia

Conditions

  • Pressor Response

Interventions

DRUG

Lignocaine

preoperative nebulization of lignocaine

DRUG

Placebo

preoperative nebulization of normal saline (Nacl 0.9%) as a placebo

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-24
Primary Completion
2022-02-23
Completion
2022-02-23

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04441073 on ClinicalTrials.gov